The American Diabetes Association® (ADA) is pleased to announce this year's National Scientific and Health Care Achievement Award recipients. The awards honor academics, clinicians, and educators who ...

Combining high-intensity circuit training with a sleep health program is tied to better sleep outcomes in sedentary women ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

Namodenoson’s Favorable Safety Profile and Broad Patent Portfolio Positions it as a Promising Candidate in the Growing Obesity Treatment Market Ramat Gan, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Can ...

Research shows that abdominal or visceral fat, the deep fat surrounding internal organs is strongly linked with cancer risk, ...

A new study suggests that combining two medicines may help people lose a large amount of weight while protecting their muscles at the same time. The research looked at a treatment that uses ...

Obesity research has become increasingly relevant as global rates of overweight and obesity continue to rise, affecting all age groups and communities.

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling pathways, results in greater weight loss while also ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

By Dr. Liji Thomas, MD A growing body of research suggests that the gut microbiome may influence the hormonal and metabolic disruptions seen in PCOS. Scientists now propose that postbiotics, bioactive ...